SAGE's (SAGE) zuranalone Risk/Benefit Not Very Favorable, Opportunity is Niche - Analyst
Go back to SAGE's (SAGE) zuranalone Risk/Benefit Not Very Favorable, Opportunity is Niche - AnalystBIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 206.20 +1.98 (0.97%) | |||||
---|---|---|---|---|---|---|
Previous Close | $204.22 | 52 Week High | $333.65 | |||
Open | $205.26 | 52 Week Low | $223.02 | |||
Day High | $207.36 | P/E | 26.40 | |||
Day Low | $203.13 | EPS | $7.81 | |||
Volume | 1,013,334 |
Sagebrush Gold Ltd. (NASDAQ: SAGE) | Delayed: 32.24 +0.31 (0.97%) | |||||
---|---|---|---|---|---|---|
Previous Close | $31.93 | 52 Week High | $62.64 | |||
Open | $31.85 | 52 Week Low | $26.28 | |||
Day High | $32.54 | P/E | N/A | |||
Day Low | $31.23 | EPS | $-0.94 | |||
Volume | 558,229 |